Figure 6.

Expression profile for the KIT gene shows interesting patterns in the bodymap in Figure 5. KIT exhibits extremely high expression in gastrointestinal stromal tumors. KIT is known to be inhibited by Gleevec^®, demonstrating that findings like these pinpoint immediate possibilities for drug repositioning.